Millennium Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.28M | Sell |
|
|||||
|
2025
Q2 | $102M | Buy |
|
|||||
|
2025
Q1 | $47.2M | Buy |
|
|||||
|
2024
Q4 | $27.9M | Buy |
|
|||||
|
2024
Q3 | $4.62M | Buy |
|
|||||
|
2024
Q2 | $944K | Sell |
|
|||||
|
2024
Q1 | $26.2M | Sell |
|
|||||
|
2023
Q4 | $40.2M | Buy |
|
|||||
|
2023
Q3 | $3.64M | Sell |
|
|||||
|
2023
Q2 | $5.97M | Sell |
|
|||||
|
2023
Q1 | $87.1M | Buy |
|
|||||
|
2022
Q4 | $1.19M | Sell |
|
|||||
|
2022
Q3 | $2.44M | Buy |
|
|||||
|
2022
Q2 | $478K | Sell |
|
|||||
|
2022
Q1 | $27.6M | Sell |
|
|||||
|
2021
Q4 | $73.7M | Buy |
|
|||||
|
2021
Q3 | $64.3M | Buy |
|
|||||
|
2021
Q2 | $10.8M | Buy |
|
|||||
|
2021
Q1 | $4.67M | Buy |
|
|||||
|
2020
Q4 | $2.89M | Sell |
|
|||||
|
2020
Q3 | $12K | Sell |
|
|||||
|
2020
Q2 | $75.8M | Buy |
|
|||||
|
2020
Q1 | $61.1M | Buy |
|
|||||
|
2019
Q4 | – | Hold |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $32.2M | Sell |
|
|||||
|
2019
Q1 | $97M | Buy |
|
|||||
|
2018
Q4 | $47.3M | Sell |
|
|||||
|
2018
Q3 | $120M | Buy |
|
|||||
|
2018
Q2 | $67.2M | Sell |
|
|||||
|
2018
Q1 | $79.8M | Buy |
|
|||||
|
2017
Q4 | $42.1M | Sell |
|
|||||
|
2017
Q3 | $71.6M | Buy |
|
|||||
|
2017
Q2 | $6.73M | Sell |
|
|||||
|
2017
Q1 | $102M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $22.6M | Buy |
|
|||||
|
2016
Q2 | $1.78M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $17.1M | Buy |
|
|||||
|
2015
Q3 | $12.2M | Sell |
|
|||||
|
2015
Q2 | $26.8M | Buy |
|
|||||
|
2015
Q1 | $18.8M | Sell |
|
|||||
|
2014
Q4 | $33.3M | Sell |
|
|||||
|
2014
Q3 | $34.7M | Buy |
|
|||||
|
2014
Q2 | $5.11M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $2.88M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $319K | Buy |
|